Improved cardiac-specific delivery of RAGE siRNA within small extracellular vesicles engineered to express intense cardiac targeting peptide attenuates myocarditis

Small extracellular vesicles (sEVs) are nanometer-sized membranous vesicles secreted by cells, with important roles in physiological and pathological processes. Recent research has established the application of sEVs as therapeutic vehicles in various conditions, including heart disease. However, th...

Full description

Bibliographic Details
Main Authors: Hyoeun Kim, Dasom Mun, Ji-Young Kang, Seung-Hyun Lee, Nuri Yun, Boyoung Joung
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253121001128
_version_ 1818929973407252480
author Hyoeun Kim
Dasom Mun
Ji-Young Kang
Seung-Hyun Lee
Nuri Yun
Boyoung Joung
author_facet Hyoeun Kim
Dasom Mun
Ji-Young Kang
Seung-Hyun Lee
Nuri Yun
Boyoung Joung
author_sort Hyoeun Kim
collection DOAJ
description Small extracellular vesicles (sEVs) are nanometer-sized membranous vesicles secreted by cells, with important roles in physiological and pathological processes. Recent research has established the application of sEVs as therapeutic vehicles in various conditions, including heart disease. However, the high risk of off-target effects is a major barrier for their introduction into the clinic. This study evaluated the use of modified sEVs expressing high levels of cardiac-targeting peptide (CTP) for therapeutic small interfering RNA (siRNA) delivery in myocarditis, an inflammatory disease of heart. sEVs were extracted from the cell culture medium of HEK293 cells stably expressing CTP-LAMP2b (referred to as C-sEVs). The cardiac targeting ability of C-sEVs with the highest CTP-LAMP2b expression was >2-fold greater than that of normal sEVs (N-sEVs). An siRNA targeting the receptor for advanced glycation end products (RAGE) (siRAGE) was selected as a therapeutic siRNA and loaded into C-sEVs. The efficiency of cardiac-specific siRNA delivery via C-sEVs was >2-fold higher than that via N-sEVs. Furthermore, siRAGE-loaded C-sEVs attenuated inflammation in both cell culture and an in vivo model of myocarditis. Taken together, C-sEVs may be a useful drug delivery vehicle for the treatment of heart disease.
first_indexed 2024-12-20T03:53:18Z
format Article
id doaj.art-5120cedaa63d4a62a422f0793d41c06a
institution Directory Open Access Journal
issn 2162-2531
language English
last_indexed 2024-12-20T03:53:18Z
publishDate 2021-06-01
publisher Elsevier
record_format Article
series Molecular Therapy: Nucleic Acids
spelling doaj.art-5120cedaa63d4a62a422f0793d41c06a2022-12-21T19:54:24ZengElsevierMolecular Therapy: Nucleic Acids2162-25312021-06-012410241032Improved cardiac-specific delivery of RAGE siRNA within small extracellular vesicles engineered to express intense cardiac targeting peptide attenuates myocarditisHyoeun Kim0Dasom Mun1Ji-Young Kang2Seung-Hyun Lee3Nuri Yun4Boyoung Joung5Division of Cardiology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea; Brain Korea 21 PLUS Project for Medical Science, Yonsei University, Seoul 03722, Republic of KoreaDivision of Cardiology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea; Brain Korea 21 PLUS Project for Medical Science, Yonsei University, Seoul 03722, Republic of KoreaDivision of Cardiology, Yonsei University College of Medicine, Seoul 03722, Republic of KoreaDepartment of Biochemistry and Molecular Biology, Yonsei University College of Medicine, Seoul 03722, Republic of KoreaInstitute of Life Science & Biotechnology, Yonsei University, Seoul 03722, Republic of Korea; Department of Systems Biology, Yonsei University College of Life Science and Biotechnology, Seoul 03722, Republic of Korea; Corresponding author: Nuri Yun, PhD, Institute of Life Science & Biotechnology, Yonsei University, Seoul 03722, Republic of Korea.Division of Cardiology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea; Brain Korea 21 PLUS Project for Medical Science, Yonsei University, Seoul 03722, Republic of Korea; Corresponding author: Boyoung Joung, MD, PhD, Division of Cardiology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.Small extracellular vesicles (sEVs) are nanometer-sized membranous vesicles secreted by cells, with important roles in physiological and pathological processes. Recent research has established the application of sEVs as therapeutic vehicles in various conditions, including heart disease. However, the high risk of off-target effects is a major barrier for their introduction into the clinic. This study evaluated the use of modified sEVs expressing high levels of cardiac-targeting peptide (CTP) for therapeutic small interfering RNA (siRNA) delivery in myocarditis, an inflammatory disease of heart. sEVs were extracted from the cell culture medium of HEK293 cells stably expressing CTP-LAMP2b (referred to as C-sEVs). The cardiac targeting ability of C-sEVs with the highest CTP-LAMP2b expression was >2-fold greater than that of normal sEVs (N-sEVs). An siRNA targeting the receptor for advanced glycation end products (RAGE) (siRAGE) was selected as a therapeutic siRNA and loaded into C-sEVs. The efficiency of cardiac-specific siRNA delivery via C-sEVs was >2-fold higher than that via N-sEVs. Furthermore, siRAGE-loaded C-sEVs attenuated inflammation in both cell culture and an in vivo model of myocarditis. Taken together, C-sEVs may be a useful drug delivery vehicle for the treatment of heart disease.http://www.sciencedirect.com/science/article/pii/S2162253121001128small extracellular vesiclescardiac-targeting peptideheart-specific deliverysmall interfering RNAmyocarditis
spellingShingle Hyoeun Kim
Dasom Mun
Ji-Young Kang
Seung-Hyun Lee
Nuri Yun
Boyoung Joung
Improved cardiac-specific delivery of RAGE siRNA within small extracellular vesicles engineered to express intense cardiac targeting peptide attenuates myocarditis
Molecular Therapy: Nucleic Acids
small extracellular vesicles
cardiac-targeting peptide
heart-specific delivery
small interfering RNA
myocarditis
title Improved cardiac-specific delivery of RAGE siRNA within small extracellular vesicles engineered to express intense cardiac targeting peptide attenuates myocarditis
title_full Improved cardiac-specific delivery of RAGE siRNA within small extracellular vesicles engineered to express intense cardiac targeting peptide attenuates myocarditis
title_fullStr Improved cardiac-specific delivery of RAGE siRNA within small extracellular vesicles engineered to express intense cardiac targeting peptide attenuates myocarditis
title_full_unstemmed Improved cardiac-specific delivery of RAGE siRNA within small extracellular vesicles engineered to express intense cardiac targeting peptide attenuates myocarditis
title_short Improved cardiac-specific delivery of RAGE siRNA within small extracellular vesicles engineered to express intense cardiac targeting peptide attenuates myocarditis
title_sort improved cardiac specific delivery of rage sirna within small extracellular vesicles engineered to express intense cardiac targeting peptide attenuates myocarditis
topic small extracellular vesicles
cardiac-targeting peptide
heart-specific delivery
small interfering RNA
myocarditis
url http://www.sciencedirect.com/science/article/pii/S2162253121001128
work_keys_str_mv AT hyoeunkim improvedcardiacspecificdeliveryofragesirnawithinsmallextracellularvesiclesengineeredtoexpressintensecardiactargetingpeptideattenuatesmyocarditis
AT dasommun improvedcardiacspecificdeliveryofragesirnawithinsmallextracellularvesiclesengineeredtoexpressintensecardiactargetingpeptideattenuatesmyocarditis
AT jiyoungkang improvedcardiacspecificdeliveryofragesirnawithinsmallextracellularvesiclesengineeredtoexpressintensecardiactargetingpeptideattenuatesmyocarditis
AT seunghyunlee improvedcardiacspecificdeliveryofragesirnawithinsmallextracellularvesiclesengineeredtoexpressintensecardiactargetingpeptideattenuatesmyocarditis
AT nuriyun improvedcardiacspecificdeliveryofragesirnawithinsmallextracellularvesiclesengineeredtoexpressintensecardiactargetingpeptideattenuatesmyocarditis
AT boyoungjoung improvedcardiacspecificdeliveryofragesirnawithinsmallextracellularvesiclesengineeredtoexpressintensecardiactargetingpeptideattenuatesmyocarditis